.svg){kind=small}
Nov-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Chime & Chill has demonstrated a consistent performance in the New York market within the Tincture & Sublingual category. Over the past four months, the brand has maintained a steady rank of 12th, indicating a stable presence in the competitive landscape. This consistency is further supported by a noticeable upward trend in sales, with a significant increase from August to November. Such stability in ranking and growth in sales suggest that Chime & Chill has successfully carved out a niche in the New York market, appealing to a dedicated consumer base.
However, the brand's absence from the top 30 rankings in other states or provinces might be a cause for concern, or perhaps an opportunity for targeted expansion. The lack of presence in these markets could indicate either a strategic focus on the New York market or potential challenges in scaling their operations or appeal elsewhere. This situation presents a dual narrative: while Chime & Chill enjoys a strong foothold in New York, exploring other regions could be key to unlocking broader growth opportunities.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in New York, Chime & Chill has shown consistent performance, maintaining a steady rank of 12th from August to November 2025. Despite this stability, Chime & Chill faces significant competition from brands like Harney Brothers Cannabis, which improved its rank from 10th in August to 9th in November, reflecting a positive sales trajectory. Meanwhile, Canna Clinicals experienced a rank fluctuation, dropping from 8th in October to 10th in November, potentially indicating a volatile sales pattern. Jumbodose saw a decline in rank from 8th in August to 13th in November, suggesting a downward trend in sales. Chime & Chill's consistent rank amidst these shifts highlights its stable market position, but the brand may need to strategize to enhance its competitive edge against brands with upward sales momentum like Harney Brothers Cannabis.
Notable Products
In November 2025, the top-performing product for Chime & Chill was K.O. - CBD Double Dose Tincture (4500mg CBD, 30ml), maintaining its leading position for four consecutive months, with sales reaching 302 units. The CBD/CBN 2:1 PM Lotion (300mg CBD, 150mg CBN) also held steady at the second rank, although its sales figures saw a decline from previous months. The K.O- CBD The Money Melon Distillate Disposable (1g) remained at the third position, consistent with its October ranking, but experienced a drop in sales compared to the previous month. Notably, the CBD/CBC/CBT/CBN 10:5:5:1 iT'S MINT - Dark Chocolate with Mint Drift Away Melts and Light & Sweet - CBD/CBC/CBG 4:5:5 White Chocolate & Espresso Pick-Me-Up Melts both climbed to the fourth position, showing a significant rise in popularity since their introduction. This shift indicates a growing consumer interest in edible products within Chime & Chill's lineup.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
